19th EuroQSAR

Knowledge Enabled Ligand Design

 Vienna, Austria    August 26-30, 2012

Committees


Organising Committee

Chairman

Gerhard ECKER

University of Vienna, Vienna, Austria

Members

Gabriele COSTANTINO

University of Parma, Parma, Italy

Anna LINUSSON

Umea University, Umea, Sweden

David LLOYD

Trinity College Dublin, Dublin, Ireland

Jordi MESTRES

IMIM and University Pompeu Fabra, Girona, Spain

Tudor I. OPREA

University of New Mexico, Albuquerque, United States

Vladimir POROIKOV

Institute of Biomedical Chemistry, Moscow, Russia

Gisbert SCHNEIDER

ETH Zürich, Zurich, Switzerland

Anna TSANTILI-KAKOULIDOU

University of Athens, Athens, Greece

Scientific Advisory Board

Members

Dimitris AGRAFIOTIS

Johnson & Johnson Pharmaceutical R&D, Philadelphia, United States

Esin AKI-YALCIN

Ankara University, Ankara, Turkey

Michael BARNES

Open Innovation, Stevenage, United Kingdom

Niklas BLOMBERG

AstraZeneca, Cambridgeshire, United Kingdom

Scott BOYER

AstraZeneca, Barcelona, Spain

Soren BRUNAK

Technical University of Denmark, Kongens Lyngby, Denmark

Andrea CAVALLI

University of Bologna and IIT, Bologna, Italy

Hiroshi CHUMAN

University of Tokushima, Tokushima, Japan

Mark CRONIN

Liverpool John Moores University, Liverpool, United Kingdom

John DEARDEN C.

Liverpool John Moores University, Liverpool, United Kingdom

Emilio Xavier ESPOSITO

exeResearch LLC, East Lansing, United States

Kimito FUNATSU

University of Tokyo, Tokyo, Japan

Johan GOTTFRIES

University of Gothenburg, Göteborg, Sweden

Eric HAAKSMA

Boehringer Ingelheim Austria, Wien, Austria

Gerhard HESSLER

Sanofi-Aventis Deutschland, Frankfurt am Main, Germany

Alexander HILLISCH

Bayer, Monheim am Rhein, Germany

Andrew HOPKINS

University of Dundee, Dundee, United Kingdom

Edgar JACOBY

Novartis Institutes for BioMedical Research, Basel, Switzerland

Ajay N JAIN

University of California, San Francisco, United States

William L. JORGENSEN

Yale University, New Haven, United States

Jan M. KRIEGL

Boehringer-Ingelheim, Biberach, Germany

Hugo KUBINYI

University of Heidelberg, Weisenheim am Sand, Germany

Luhua LAI

Peking University, Beijing, China

Thierry LANGER

Prestwick Chemical, Vienna, Austria

Andrew R. LEACH

GSK, Hinxton, United Kingdom

Paul LEESON

GlaxoSmithKline, Nuneaton, United Kingdom

David T MANALLACK

Monash University, Parkville, Australia

Yvonne C. MARTIN

Martin Consulting, Waukegan, United States

Anthony NICHOLLS

OpenEye Scientific Software, Santa Fe, United States

Kyoung Tai NO

Yonsei University, Seoul, Korea, South

Alessandro PADOVA

Siena Biotech, Siena, Italy

Vladimir A. PALYULIN

M.V.Lomonosov Moscow State University, Moscow, Russia

Matthias RAREY

University of Hambourg, Hamburg, Germany

Ferran SANZ

University Pompeu Fabra, Barcelona, Spain

Anil SAXENA

Central Drug Research Institute, Lucknow, India

Klaus-Jürgen SCHLEIFER

BASF, Ludwigshafen, Germany

Tanja SCHULZ-GASCH

F. Hoffmann-La Roche, Basel, Switzerland

Brian SHOICHET

University of California San Francisco, San Francisco CA, Canada

Wolfgang SIPPL

Martin-Luther-Universität Halle-Wittenberg, Halle, Germany

Alexander TROPSHA

University of North Carolina, Chapel Hill, United States

Nico VERMEULEN

VU University, Amsterdam, The Netherlands

Rebecca WADE

Heidelberg University and HITS, Heidelberg, Germany

Renxiao WANG

Shanghai Institute of Organic Chemistry, Shanghai, China

Anthony WILLIAMS

RSC - ChemSpider, Raleigh-Durham, United States

Bryn I. WILLIAMS-JONES

Pfizer, Kent, United Kingdom

David WINKLER

Csiro Molecular Science, Clayton, Australia

Ismail YALCIN

Ankara University, Ankara, Turkey